Eye Diseases: Clinical Trials

14,655 trials for Eye Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8413 completed, 2315 unknown, 1373 recruiting, 856 terminated. 5250 Not applicable, 2156 Phase 2, 1577 Phase 3, 1261 Phase 4, 1222 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5250Completed 2939, Unknown 920, Recruiting 497, Terminated 260, Not yet recruiting 254, Active not recruiting 176, Withdrawn 144, Enrolling by invitation 49, Suspended 11
Phase 22156Completed 1249, Unknown 260, Terminated 210, Recruiting 175, Active not recruiting 98, Withdrawn 91, Not yet recruiting 56, Enrolling by invitation 12, Suspended 5
Phase 31577Completed 993, Unknown 197, Terminated 132, Recruiting 109, Active not recruiting 57, Withdrawn 48, Not yet recruiting 34, Suspended 5, Enrolling by invitation 2
Phase 41261Completed 806, Unknown 186, Terminated 77, Recruiting 69, Withdrawn 53, Not yet recruiting 46, Active not recruiting 19, Enrolling by invitation 4, Suspended 1
Phase 11222Completed 692, Unknown 140, Recruiting 134, Terminated 99, Active not recruiting 64, Withdrawn 42, Not yet recruiting 41, Enrolling by invitation 7, Suspended 3
Early Phase 1156Completed 61, Recruiting 30, Unknown 29, Not yet recruiting 16, Withdrawn 7, Terminated 5, Active not recruiting 4, Suspended 3, Enrolling by invitation 1

Follow Eye Diseases: new trials by email Literature Review of Eye Diseases trials Research Report on Eye Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
brimonidine tartrate ophthalmic solution 0.025%, sterile balanced saline solution - Glaucoma, Glaucoma, Open-Angle
Phase 4Not yet recruitingTulane University602027-11-012026-10-13
A Phase 2 Study of RCI001 Ophthalmic Solution in Participants With Dry Eye Disease
RCI001 Ophthalmic Solution, Placebo Ophthalmic Solution - Dry Eye
Phase 2Not yet recruitingRudacure2002027-09-012026-06-04
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®
PRO-240, Optive® - Dry Eye Disease, Dry Eye Sensation
Phase 1Not yet recruitingLaboratorios Sophia S.A de C.V.322027-07-302026-11-10
Know Your Pressures NYC
Virtual Automated Navigator Intervention with Health Education, Usual Care - Glaucoma, Hypertension
Not applicableNot yet recruitingColumbia University70852027-07-012026-08-25
Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease
MHB018A injection - Thyroid Eye Disease (TED)
Phase 3Not yet recruitingMinghui Pharmaceutical (Hangzhou) Ltd2192027-07-012026-06-04
joyVision: The Superiority of Co-design in the Development of a Serious Game for Children With Cerebral Visual Impairment
serious game - Cerebral Visual Impairment
Not applicableNot yet recruitingUniversitaire Ziekenhuizen KU Leuven342027-06-012026-10-26
Comparative Efficacy of Saccadic and Biofeedback Training in Homonymous Hemianopia
Biofeedback Fixation Training, Saccadic Reading Training - Hemianopia, Homonymous
Not applicableSuspendedUniversity of Alabama at Birmingham202027-06-012026-09-25
Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
Moxifloxacin, Placebo - Endophthalmitis
Phase 2 / Phase 3Not yet recruitingJason Ahee, M.D.600002027-06-012026-09-15
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)
Nicotinamide, Standard Glaucoma Therapy - Glaucoma, Open-angle, Primary Open Angle Glaucoma (POAG)
Phase 2Not yet recruitingUniversity of Chicago962027-06-012026-10-13
Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss
Personalised Remapping Training, RSVP personalized remappi, Reading text in the wild with remapping - Macular Degeneration, Central Visual Impairment
Not applicableNot yet recruitingUniversity of Minnesota2162027-06-012026-10-29
Body Image, Identity Development, and Social Media Use Among Youth With Visual Impairment: A Single Case Intervention Study
Body image intervention - Visual Impairment, Cerebral Visual Impairment
Not applicableNot yet recruitingUniversitaire Ziekenhuizen KU Leuven152027-05-012026-08-03
The Emmetropization Via Accommodation (EVA) - II Study
Experimental treatment arm - Hyperopia, Farsightedness
Not applicableNot yet recruitingOhio State University522027-04-012026-09-24
Eye Health Intervention Study in Upper Manhattan
Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy
Not applicableWithdrawnColumbia University2027-04-012026-05-29
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Safety and Clinical Performance of the LENTIS® MAX LS-313 MF80 Compared With the Monofocal L-313 in Cataract Patients With Late Age-Related Macular Degeneration: A Multicenter Comparative Clinical Investigation.
Intraocular Lens - Cataract, AMD - Age-Related Macular Degeneration
Not applicableNot yet recruitingTeleon Surgical B.V.352027-02-012026-11-04
Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia
Omega-3 supplement, Warm compress, Standard eyelid cleanser - Pediatric Chalazia
Phase 2Not yet recruitingJaeb Center for Health Research1682027-02-012026-10-30
Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases
Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2 - Uveal Melanoma, Metastatic Cutaneous Melanoma
Phase 1Not yet recruitingVastra Gotaland Region62027-01-312026-09-09
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB)
Not yet recruitingBioSensics602027-01-152026-10-13
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
UPLIZNA - Neuromyelitis Optica Spectrum Disorder, Pregnancy Related
RecruitingAmgen602027-01-152026-10-29
Non-invasive Ultrasound Retinal Stimulation for Vision Restoration
Non-invasive ultrasound retinal stimulation Device - Age-Related Macular Degeneration, Retinitis Pigmentosa
Not applicableNot yet recruitingUniversity of Southern California52027-01-102026-01-08

Showing 20 of 14655. Sign in to see all of them.

Narrower conditions

Cataract (1417)  ·  Glaucoma (1364)  ·  Dry Eye Syndromes (1358)  ·  Macular Degeneration (1174)  ·  Myopia (1091)  ·  Glaucoma, Open-Angle (920)  ·  Diabetic Retinopathy (685)  ·  Ocular Hypertension (655)  ·  Refractive Errors (420)  ·  Macular Edema (418)  ·  Astigmatism (405)  ·  Vision Disorders (350)  ·  Presbyopia (334)  ·  Retinal Diseases (333)

Broader conditions

Retinal Diseases (3278)  ·  Pathological Conditions, Signs and Symptoms (2318)  ·  Nervous System Diseases (2252)  ·  Retinal Degeneration (1886)  ·  Lacrimal Apparatus Diseases (1674)  ·  Signs and Symptoms (1571)  ·  Refractive Errors (1524)  ·  Ocular Hypertension (1504)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1460)  ·  Lens Diseases (1458)  ·  Neurologic Manifestations (1406)  ·  Cardiovascular Diseases (1397)  ·  Immune System Diseases (1395)  ·  Vascular Diseases (1369)

Interventions

Ranibizumab (384)  ·  aflibercept (245)  ·  Ophthalmic Solutions (223)  ·  Bevacizumab (183)  ·  Latanoprost (169)  ·  Cataract Extraction (160)  ·  Timolol (132)  ·  Dexamethasone (129)  ·  Travoprost (105)  ·  salicylhydroxamic acid (98)  ·  Calcium Dobesilate (96)  ·  Brimonidine Tartrate (94)  ·  Phacoemulsification (92)  ·  Tomography, Optical Coherence (89)  ·  Lubricant Eye Drops (88)

Sponsors

Alcon Research (536)  ·  National Eye Institute (NEI) (238)  ·  Allergan (202)  ·  Bausch & Lomb Incorporated (161)  ·  CooperVision, Inc. (150)  ·  Sun Yat-sen University (146)  ·  Assiut University (138)  ·  Medical University of Vienna (135)  ·  Novartis Pharmaceuticals (130)  ·  Zhongshan Ophthalmic Center, Sun Yat-sen University (114)  ·  Johnson & Johnson Vision Care, Inc. (88)  ·  Johns Hopkins University (87)  ·  Fondation Ophtalmologique Adolphe de Rothschild (85)  ·  University of California, San Francisco (80)  ·  Singapore National Eye Centre (75)

Countries

United States (5358)  ·  China (1262)  ·  France (906)  ·  United Kingdom (780)  ·  Canada (712)  ·  Germany (705)  ·  Italy (566)  ·  Spain (544)  ·  Austria (430)  ·  Egypt (393)  ·  South Korea (363)  ·  Australia (346)  ·  Israel (286)  ·  Taiwan (281)  ·  Turkey (Türkiye) (274)

Top investigators

Georgios Labiris, MD, PhD (26)  ·  Gail Torkildsen, MD (21)  ·  Emily Y Chew, M.D. (15)

Results publications

PMID 36809645, PMID 37314061, PMID 35943114, PMID 40522203, PMID 36912740, PMID 37702300, PMID 10937547, PMID 20451898, PMID 30194931, PMID 22108357, PMID 32408387, PMID 32557558, PMID 36729473, PMID 26875007, PMID 32374423, PMID 32573764, PMID 34707360, PMID 36912792, PMID 37260074, PMID 40547876, PMID 12649304, PMID 12823990, PMID 24974815, PMID 25179431, PMID 30957581, PMID 32280196, PMID 33263359, PMID 36449262, PMID 9778415, PMID 12719068, PMID 14508260, PMID 17122118, PMID 22281388, PMID 23049090, PMID 25458728, PMID 26089210, PMID 27929721, PMID 28736340, PMID 32844399, PMID 34108929, PMID 34516656, PMID 34934034, PMID 37172782, PMID 37619861, PMID 39758130, PMID 39839752, PMID 10815152, PMID 11237914, PMID 11879137, PMID 12049574

NIH funding

2019 (38), 2014 (33), U10EY011751 (33), 2018 (31), 2023 (28), 2025 (26), 2009 (25), 2016 (25), 2015 (24), 2017 (22), 2008 (11), U01CA081457 (9), U10CA098543 (9), U10EY014231 (9), 2005 (8)